Search results
FDA grants approval for two Eylea biosimilars for eye conditions
Pharmaceutical Technology via Yahoo Finance· 3 hours agoThe US Food and Drug Administration (FDA) has approved Yesafili (aflibercept-jbvf) and Opuviz...
FDA Grants Withdrawal of Infigratinib for Cholangiocarcinoma
Medscape· 7 hours agoThe US Food and Drug Administration (FDA) has announced the withdrawal of its 2021 accelerated approval of infigratinib (Truseltiq) for patients with a certain type of previously ...
FDA Approves Pivya, a New Treatment for UTIs in Women
Health.com· 20 hours agoThe drug, Pivya (pivmecillinam), is approved to treat women over 18 with uncomplicated UTIs, which...
FDA Withdraws Approval of FGFR Inhibitor for Bile Duct Cancer
MedPage Today· 1 day agoThe FDA has withdrawn the approval of infigratinib (Truseltiq) as a second-line treatment for...
FDA approves lung cancer treatment
CW39 NewsFix· 11 hours ago(KIAH) – Lung Cancer is a complex and devastating disease with over 200,000 new cases in 2024 alone. Small Cell Lung Cancer, or SCLC, is one of the most aggressive cancers out there, reportin…
Biocon Biologics gets US FDA nod for biosimilar version of eye treatment drug Eylea
Investing.com· 7 hours agoBiocon Biologics gets US FDA nod for biosimilar version of eye treatment drug Eylea
One year after FDA approves over-the-counter birth control pill, advocates push for more access
Idaho Capital Sun via Yahoo News· 1 day agoStates. “My parents are immigrants from India, and it’s been over the counter there since my mom can...
Neuralink To Test Brain Implant On Second Patient - Slashdot
Slashdot· 5 hours agoThe FDA has approved Neuralink to implant its brain chip in a second patient. According to the Wall Street Journal, the company also outlined fixes to an ...
LDTs: FDA Rolls Out a Phased Implementation for New Regulatory Requirements
The National Law Review· 22 hours agoOn May 6, 2024, the U.S. Food and Drug Administration (FDA) issued its final rule significantly...
FDA Approves First Interchangeable Biosimilars to Aflibercept for AMD
MedPage Today· 1 day agoThe FDA approved the first interchangeable biosimilars to aflibercept (Eylea) to treat macular degeneration, according to an announcement from the agency ...